The Centers for Medicare & Medicaid Services (CMS) will increase the reimbursement for at-home COVID-19 vaccines by $35 per vaccination when the shots are administered to multiple residents in one home or communal home setting. This new amount is on top of the earlier increase in June for vaccines administered in a beneficiary’s home.
On Aug. 26, 43 members of the U.S. Senate, including Sens. Feinstein and Padilla, sent a bipartisan letter to Health & Human Services Secretary Xavier Becerra calling for the immediate release of the remaining Provider Relief Funds to hospitals and providers.
This post has been archived and contains information that may be out of date.
onday’s full approval by the Food and Drug Administration (FDA) of the Pfizer COVID-19 vaccine is welcome news for our nation and state as we continue the climb toward more universal protection from this deadly pandemic.
On Aug. 20, CDPH issued FAQs on the state public health officer order on hospital visitation. This health order requires vaccine verification or proof of a COVID-19 test for visitors of hospitals and other facilities. The FAQs provide clarifications, in addition to those issued in All Facilities Letter (AFL) 21-31, on who is covered by...
The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S.
On Aug. 20, CDPH issued FAQs on the state public health officer order on hospital visitation. This health order requires vaccine verification or proof of a COVID-19 test for visitors of hospitals and other facilities. The FAQs provide clarifications, in addition to those issued in All Facilities Letter (AFL) 21-31, on who is covered by the order and who is...
The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S.
On Aug. 20, the Centers for Medicare & Medicaid Services’ Center for Consumer Information and Insurance Oversight issued frequently asked questions (FAQs) on the several price transparency requirements related to health plans and included in the No Surprises Act.
CHA members are invited to register for DataGen’s webinar on the federal fiscal year 2022 inpatient prospective payment system final rule and analysis on Sept. 2 at noon (PT). Registration is required, and a recording will be available.
CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of the federal fiscal year 2022 skilled-nursing facility (SNF) prospective payment system final rule. The regulation is effective Oct. 1.
